Renal stone disease, elevated iPTH level and normocalcemia

International Urology and Nephrology

Volumn 34, Issue 1, 2002, Pages 135-141

  Dimkovic, N B ^a   Wallele, A A ^a   Oreopoulos, D G ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Hyperparathyroidism; Normocalcemia; Renal stone disease

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; ALKALINE PHOSPHATASE; CALCIUM; CITRIC ACID; CREATININE; HEMOGLOBIN; HYDROXYPROLINE; MAGNESIUM; OXALIC ACID; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS; SODIUM;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CANADA; CATHETERIZATION; CLINICAL EXAMINATION; CORRELATION ANALYSIS; DISEASE DURATION; FAMILY HISTORY; FEMALE; HOSPITAL; HUMAN; HYDROXYPROLINE URINE LEVEL; IMMOBILIZATION; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; LABORATORY TEST; LITHOTRIPSY; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; MULTIPLE REGRESSION; NEPHRECTOMY; NEPHROLITHIASIS; NEPHROLITHOTOMY; ORGAN WEIGHT; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PARATHYROIDECTOMY; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; RECURRENT DISEASE; RISK FACTOR; SODIUM URINE LEVEL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STONE FORMATION; URETEROLITHOTOMY; URINARY EXCRETION; URINE OSMOLALITY; URINE VOLUME; VITAMIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; CALCIUM; FEMALE; HUMANS; KIDNEY CALCULI; MALE; MIDDLE AGED; PARATHYROID HORMONE; RETROSPECTIVE STUDIES;

EID: 0036945896     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021331728317     Document Type: Article

References (42)

1. Agus ZS, Goldfarb S. Clinical disorders of calcium and phospate. Med Clin North Am 1981; 65: 385-398.
2. Blind E, Schmidt-Gayk H, Scharla S, Flentje D, Fischer S, Göhring U, Hitzler W. Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay. J Clin Endocrinol Metab 1988; 67: 353-360.
3. Bordier P, Ryckewaert A, Gueris J, Rasmussen H. On the pathogenesis of so-called idiopathic hypercalciuria. Am J Med 1977; 63: 398-409.
4. Boucher A, D'Amour P, Hamel L, Fugere P, Cascon-Barre M, Lepage R. Estrogen replacement decreases the set point of parathyroid hormone stimulation of calcium in normal postmenopausal women. J Clin Endocrinol Metab 1989; 68: 831-836.
5. Carling T, Rastad J, Kindmark A, Lundren E, Ljunghall S, Kerstrom G. Estrogen receptor gene polymorphism in postmenopausal primary hyperparathyroidism. Surgery 1997; 122(6): 1101-1105.
6. Carling T, Kindmark A, Hellman P, Holmberg L, Akerstrom G, Radstad J. Vitamin D receptor alleles b, and T: Risk factors for sporadic primary hyperparathyroidism (HPT) but not HPT of uremia or MEN 1. Biochem Biophys Res Commun 1997; 231: 329-332.
7. Carling T, Akerstrom G, Rastad J, Westin G. Vitamin D receptor (VDR) and parathyroid hormone mRNA levels correspond to polymorphic VDR alleles in human prathyroid tumors. J Clin Endocrinol Metab 1998; 83: 2255-2259.
8. Coen G, Bondatti F De Matteis A, Ballanti P, Mazzeferro S, Sardella D, Samacchi A. Severe vitamin D deficiency in a case of primary hyperparathyroidism caused by parathyroid lipoadenoma. Miner Electrolyte Metab 1989; 15: 332-337.
9. Correa P, Rastad J, Schwarz P, Westin G, Kindmark A, Lundgren E, Akerstrom G, Carling T. The vitamin D receptor (VDR) start colon polymorphism in primary hyperparathyroidism and parathyroid VDR messenger ribonucleic acid levels. J Clin Endocrinol Metab 1999 84: 1690-1694.
10. Endress DB, Villanueva R, Sharp CF, Singer FR. Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: Performance in the differential diagnosis of hypercalcemia and hypoparathroidism. Clin Chem 1991; 37: 162-168.
11. Gardin JP, Paillard M. Normacalcemic primary hyperparathyoidism: Resistance to PTH effect on tubular reabsorption of calcium. Mineral Electrolyte Metab 1984; 10: 301-308.
12. Gardin JP, Houillier P, Borensztein P, Paillard M. Should the parathyroid function be evaluated in a patient with calcium kidney stones? If so, when and why? Nephrologie 1991; 12(2): 71-77.
13. George JM, Rabson AS, Ketcham A, Bartter FC. Calcareous renal disease and hyperparathyroidism. Quart J Med 1965; 34: 291-301.
14. Hackeng WHL, Lips P, Netelenbos JC, Lips CJM. Clinical implication of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients. J Clin Endocrinol Metabol 1986; 63: 447-453.
15. Joborn C, Ljunghall S, Larsson K, Lindh E, Naessen T, Wide L. Skeletal responsiveness to parathyroid hormone in healthy females: Relationship to menopause and oestrogen replacement. Clin Endocrinol 1991; 34: 335-339.
16. Johansson H, Thoren L, Werner I, Grimelius L. Normocalcemic hyperparathyroidism, kidney stones and idiopathic hypercalciuria. Surgery 1975; 77: 691-696.
17. Kao PC, Van Heerden JA, Grant CS, Klee GG, Khosla S. Clinical performance of parathyroid hormone immunometric assays. Mayo Clin Proc 1992; 67: 637-645.
18. Lindall AW, Elting J, Ells, J, Roos BA. Estimation of biologically active intact parathyroid hormone in normal and hyperparahyroid sera by sequential N-terminal immunoextraction and midregion radioimmunoassay. J Clin Endocrinol Metab 1983; 57: 1007-1014.
19. Lloyd HM, Rose GA. Ionised, protein bound and complexed calcium in the plasma in primary hyperparathyroidism. Lancet 1958; 2: 258-261.
20. Lo Cascio V, Adami S, Galvanini G. Substrate-product relation of 1 hydroxylase activity in primary hyperparathyroidism. N Engl J Med 1985; 313: 1123-1125.
21. Lundgren E, Ridefelt P, Akerstrom G, Lunghall S, Rastad J. Parathyroid tissue in normocalcemic and hypercalcemic primary hyperparathyroidism recruited by health screening. World J Surg 1996; 20(7): 727-734.
22. Lundgren E, Rastad J, Thrufjell E, Akerstrom G, Ljunghall S. Population-based screening for primary hyperparathyroidism with serum calcium and parathormone values in menopausal women. Surgery 1997; 121(3): 287-294.
23. Luong KVQ, Nguyen LTH. Normocalcemic hyperparathyroidism in Vietnamese immigrants living in Southern California. Am J Med Sci 2000; 319(6): 380-384.
24. Mather HG. Hyperparathyroidism with normal serum calcium. Brit Med J 1953; 2: 424.
25. Mawer EB, Bachouse J, Hill LF, Lumb GA, De Silva P, Taylor CM, Stanbury SW. Vitamin D metabolism and parathyroid function man. Clin Sci Mod 1975; 48: 349-365.
26. Mc Geown Mg. Effect of parathyroidectomy on the incidence of renal calculi. Lancet 1961; 1: 586.
27. Mc Geown Mg, Morrison E. Hyperparathyriodism. Postgrad Med J 1959; 35: 330.
28. Mc Leod MK, Monchik JM, Martin HG. The role of ionized calcium in the diagnosis of subtle hypercalcemia in symptomatic primary hyperparathyroidism. Surgery 1984; 95: 667-673.
29. Miline R. Biological effect of solar radiation on animals. Their histophysiological function in the neuroendocrine system. Prog Biometeorol 1974; 1(1A): 365-372, 672-673.
30. Morrison NA, Qi JC. Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-287.
31. Naveh-Many T, Almogi G, Livni N, Silver J. Estrogen receptors and biologic response in rat parathyroid tissue and C cells. J Clin Invest 1992; 90: 2434-2438.
32. Nicholas G Jr, Flanagan B. Normacalcemic hyperparathyroidism. Trans Ass Amer Phys 1967; 80: 314.
33. Nussbaum SR, Potts J.T. Immunoassays fr parathyroid hormone 1-84 in the diagnosis of hyperparathyroidism. J Bone Miner Res 1991; 6(Suppl 2): 43-50.
34. Pak CYC, East DA, Sanzenbacher LJ, Delea CS, Bartter FC. Gastrointestinal calcium absorption in nephrolithiasis. J Clin Endocrinol Metab 1972; 35: 261-270.
35. Poole GV Jr, Albertson DA, Myers RT. Normocalcemic hyperparathyroidism revisited. Am Surg 1983; 49: 668-671.
36. Rao D, Han Z-N, Phillips E, Palnitkar S, Parfitt A. Loss of calcitriol receptor expression in parathyroid adenomas: Implications for pathogenesis. J Bone Miner Res 1997; 12: s107 (Abstract).
37. Shieber W, Birge SJ, Avioh LV, Teitlebaum S. Normocalcemic hyperparathyroidism with 'normal' parathyroid glands. Arch Surg 1971; 103: 299-302.
38. Siminovitch JM, James RE, Esselstyn CB Jr, Straffon RA, Banowsky LH. The effect of parathyroidectomy in patients with normocalcemic calcium stones. J Urol 1980; 123: 335-337.
39. Siminovitch JM, Esselstyn CB, Jr, Straffon RA. Renal lithiasis and hyperparathyroidism: Diagnosis, management and prognosis. J Urol 1981; 126(6): 720-722.
40. Siperstein A, Shen W, Chan AK, Duh QY, Clark OH. Normocalcemic hyperparathyroidism. Arch Surg 1992; 127: 1157-1163.
41. Watson L. Primary hyperparathyroidism. Endocrin Metab 1974; 3: 215-235.
42. Woodhouse NJY, Doyle FH, Joplin GF. Vitamin D deficiency and primary hyperparathyroidism. Lancet 1971; ii: 283-286.